Skip to main content
Log in

In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia

  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The in vitro activity of the new naphthyridone trovafloxacin (CP 99,219) was compared with those of penicillin G and six other agents (cefpodoxime, erythromycin, azithromycin, clindamycin, ciprofloxacin, and sparfloxacin) against 316 penicillin-susceptible and -resistant pneumococci isolated in the former Czechoslovakia. Trovafloxacin was very active against strains ofStreptococcus pneumoniae (MIC50 and MIC90 0.25 Μg/ml). Ciprofloxacin was less active (MIC50 1.0 Μg/ml, MIC90 2.0 (Μg/ml), and MICs of sparfloxacin were between those of trovafloxacin and ciprofloxacin (MIC50 and MIC90 both 0.5 Μg/ml). MICs of cefpodoxime, erythromycin, azithromycin, and clindamycin were higher for strains intermediately resistant or resistant to penicillin than for penicillin-susceptible strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Appelbaum PC: Antimicrobial resistance inStreptococcus pneumoniae: an overview. Clinical Infectious Diseases 1992, 15: 77–83.

    PubMed  Google Scholar 

  2. Figueiredo AMS, Austrian R, Urbášková P, Teixeira LA, Tomasz A: Novel penicillin-resistant clones ofStreptococcus pneumoniae in the Czech Republic and Slovakia. Microbial Drug Resistance 1995, 1: 71–78.

    PubMed  Google Scholar 

  3. Klugman KP: Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 1990, 3: 171–196.

    PubMed  Google Scholar 

  4. Jacobs MR: Treatment and diagnosis of infections caused by drug-resistantStreptococcus pneumoniae. Clinical Infectious Diseases 1992, 15: 119–127.

    PubMed  Google Scholar 

  5. Klugman KP: Management of antibiotic-resistant pneumococcal infections. Journal of Antimicrobial Chemotherapy 1994, 34: 191–193.

    PubMed  Google Scholar 

  6. Pankuch GA, Jacobs MR, Appelbaum PC: Activity of CP 99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 1995, 35: 230–232.

    PubMed  Google Scholar 

  7. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1993.

    Google Scholar 

  8. Appelbaum PC: New prospects for antibacterial agents against multidrug-resistant pneumococci. Microbial Drug Resistance 1995, 1: 43–48.

    PubMed  Google Scholar 

  9. Reichler MR, Rakovsky J, Sobotová A, Sláčiková M, Hlaváčová B, Hill B, Krajčiková L, Tarina P, Facklam RR, Breiman RF: Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. Journal of Infectious Diseases 1995, 171: 1491–1496.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Urbášková, P., Trupl, J., Hupková, H. et al. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia. Eur. J. Clin. Microbiol. Infect. Dis. 15, 686–688 (1996). https://doi.org/10.1007/BF01691161

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01691161

Keywords

Navigation